RecalledThisWeek Search
Low risk Drugs & MedicationsClass III

Trokendi XR Topiramate 25mg Recall

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40

Updated July 6, 2026

Trokendi XR 25mg capsules are being recalled because some batches failed to meet dissolution specifications, meaning the capsules may not release the medication properly in your body. Talk to your doctor or pharmacist before stopping this medication.

Is the Supernus Pharmaceuticals, Inc. recalled? Yes. This product was recalled by FDA on July 6, 2026. Details below.

What is recalled

Trokendi XR (topiramate extended-release capsules), 25mg, 30 capsules per bottle, NDC 17772-101-30. Manufactured by Catalent Pharma Solutions in Winchester, Kentucky for Supernus Pharmaceuticals, Inc.

Am I affected

You're affected if your prescription bottle shows Trokendi XR 25mg, 30 capsules, NDC 17772-101-30. Check the label for the NDC number and product name.

What to do right now

Contact your doctor or pharmacist about this recall. Do not stop taking your medication without medical guidance. Your healthcare provider will tell you whether to switch to a replacement or continue your current supply.

The hazard

Failed Dissolution Specifications

Brands affected

Supernus Pharmaceuticals, Inc.
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0758-2026
Classification
Class III
Recalled
July 6, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls